[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fbkK5okLTSQxWvH75z0ORfGNGK_v2MNb2yUA_Z49Y2Ik":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":8,"nonDrugCount":8,"topConditions":11,"upcomingReadouts":29,"phaseBuckets":30,"rows":37},"Sanotize Research and Development corp.",[4],9,false,0,2,2122,[12,14,17,19,21,23,25,27],{"name":13,"count":9},"SARS-CoV-2 Infection",{"name":15,"count":16},"SARS-CoV Infection",1,{"name":18,"count":16},"Recurrent Acute Rhinosinusitis",{"name":20,"count":16},"Chronic Sinusitis",{"name":22,"count":16},"Corona Virus Infection",{"name":24,"count":16},"Diabetic Foot Ulcer",{"name":26,"count":16},"Verruca Plantaris",{"name":28,"count":16},"Candidiasis, Oral",[],[31,32,33,34,35,36],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[38,105,130,155,173,198,223],{"intervention":39,"totalTrials":40,"cells":41},"Nitric Oxide",5,{"EARLY_PHASE1":42,"PHASE1":44,"PHASE2":56,"PHASE3":78,"PHASE4":101,"NA":103},{"trials":43,"activeCount":8},[],{"trials":45,"activeCount":8},[46],{"nctId":47,"briefTitle":48,"status":49,"phases":50,"primaryCompletion":51,"completion":51,"start":52,"enrollment":53,"conditions":54,"interventions":55},"NCT06120816","Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis","COMPLETED",[32],"2024-05-25","2024-01-20",6,[28],[39],{"trials":57,"activeCount":8},[58,68],{"nctId":59,"briefTitle":60,"status":49,"phases":61,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":65,"interventions":66},"NCT04163978","Nitric Oxide Releasing Sinus Irrigation (NOSi) to Treat Recalcitrant Chronic Rhinosinusitis (RCRS)",[33],"2022-05-03","2019-10-27",56,[20],[39,67],"Budesonide",{"nctId":69,"briefTitle":70,"status":49,"phases":71,"primaryCompletion":72,"completion":73,"start":74,"enrollment":75,"conditions":76,"interventions":77},"NCT05877313","Nitric Oxide Releasing Solution (NORS) For The Treatment Of Human Papillomavirus(HPV) Verrucae Plantaris (Plantar Warts)",[33],"2024-02-01","2024-04-12","2023-08-02",20,[26],[39],{"trials":79,"activeCount":8},[80,91],{"nctId":81,"briefTitle":82,"status":83,"phases":84,"primaryCompletion":85,"completion":86,"start":87,"enrollment":88,"conditions":89,"interventions":90},"NCT05109611","Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection","TERMINATED",[34],"2024-01-30","2024-04-30","2021-11-20",1389,[13],[39],{"nctId":92,"briefTitle":93,"status":49,"phases":94,"primaryCompletion":95,"completion":96,"start":97,"enrollment":98,"conditions":99,"interventions":100},"NCT05599919","Nitric Oxide Nasal Spray (NONS) To Treat and Prevent the Exacerbation of Infection in Individuals With Mild COVID-19",[34],"2022-01-31","2022-02-02","2021-11-01",306,[13],[39],{"trials":102,"activeCount":8},[],{"trials":104,"activeCount":8},[],{"intervention":106,"totalTrials":16,"cells":107},"Nitric Oxide-Releasing Drug",{"EARLY_PHASE1":108,"PHASE1":110,"PHASE2":112,"PHASE3":124,"PHASE4":126,"NA":128},{"trials":109,"activeCount":8},[],{"trials":111,"activeCount":8},[],{"trials":113,"activeCount":8},[114],{"nctId":115,"briefTitle":116,"status":117,"phases":118,"primaryCompletion":119,"completion":120,"start":121,"enrollment":8,"conditions":122,"interventions":123},"NCT04443868","Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection","WITHDRAWN",[33],"2021-04","2021-07","2021-01",[15],[106],{"trials":125,"activeCount":8},[],{"trials":127,"activeCount":8},[],{"trials":129,"activeCount":8},[],{"intervention":131,"totalTrials":16,"cells":132},"Nitric Oxide Releasing Solution",{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":149,"PHASE4":151,"NA":153},{"trials":134,"activeCount":8},[],{"trials":136,"activeCount":8},[],{"trials":138,"activeCount":8},[139],{"nctId":140,"briefTitle":141,"status":49,"phases":142,"primaryCompletion":143,"completion":144,"start":145,"enrollment":146,"conditions":147,"interventions":148},"NCT06264141","Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis",[33],"2025-02-22","2025-11-22","2024-01-16",162,[18],[131],{"trials":150,"activeCount":8},[],{"trials":152,"activeCount":8},[],{"trials":154,"activeCount":8},[],{"intervention":67,"totalTrials":16,"cells":156},{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":167,"PHASE4":169,"NA":171},{"trials":158,"activeCount":8},[],{"trials":160,"activeCount":8},[],{"trials":162,"activeCount":8},[163],{"nctId":59,"briefTitle":60,"status":49,"phases":164,"primaryCompletion":62,"completion":62,"start":63,"enrollment":64,"conditions":165,"interventions":166},[33],[20],[39,67],{"trials":168,"activeCount":8},[],{"trials":170,"activeCount":8},[],{"trials":172,"activeCount":8},[],{"intervention":174,"totalTrials":16,"cells":175},"NORS",{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":192,"PHASE4":194,"NA":196},{"trials":177,"activeCount":8},[],{"trials":179,"activeCount":8},[],{"trials":181,"activeCount":8},[182],{"nctId":183,"briefTitle":184,"status":49,"phases":185,"primaryCompletion":186,"completion":187,"start":188,"enrollment":189,"conditions":190,"interventions":191},"NCT04337918","Nitric Oxide Releasing Solutions to Prevent and Treat Mild\u002FModerate COVID-19 Infection",[33],"2021-01-31","2021-02-02","2020-05-08",143,[22],[174,174],{"trials":193,"activeCount":8},[],{"trials":195,"activeCount":8},[],{"trials":197,"activeCount":8},[],{"intervention":199,"totalTrials":16,"cells":200},"Nitric Oxide-Releasing Solution",{"EARLY_PHASE1":201,"PHASE1":203,"PHASE2":205,"PHASE3":217,"PHASE4":219,"NA":221},{"trials":202,"activeCount":8},[],{"trials":204,"activeCount":8},[],{"trials":206,"activeCount":8},[207],{"nctId":208,"briefTitle":209,"status":49,"phases":210,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":214,"interventions":215},"NCT04755647","Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers",[32,33],"2023-05-20","2021-02-23",40,[24],[199,216],"Saline solution, hypotonic",{"trials":218,"activeCount":8},[],{"trials":220,"activeCount":8},[],{"trials":222,"activeCount":8},[],{"intervention":216,"totalTrials":16,"cells":224},{"EARLY_PHASE1":225,"PHASE1":227,"PHASE2":229,"PHASE3":235,"PHASE4":237,"NA":239},{"trials":226,"activeCount":8},[],{"trials":228,"activeCount":8},[],{"trials":230,"activeCount":8},[231],{"nctId":208,"briefTitle":209,"status":49,"phases":232,"primaryCompletion":211,"completion":211,"start":212,"enrollment":213,"conditions":233,"interventions":234},[32,33],[24],[199,216],{"trials":236,"activeCount":8},[],{"trials":238,"activeCount":8},[],{"trials":240,"activeCount":8},[]]